Y
Yong Kim
Researcher at Case Western Reserve University
Publications - 2
Citations - 2117
Yong Kim is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Chemotherapy & Performance status. The author has an hindex of 1, co-authored 2 publications receiving 2055 citations.
Papers
More filters
Journal ArticleDOI
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Frances A. Shepherd,Janet Dancey,Rodryg Ramlau,Karin Mattson,Richard J. Gralla,Mark Allen O'Rourke,Nathan Levitan,Laurent Gressot,Mark Vincent,Ronald L. Burkes,Susan Coughlin,Yong Kim,Jocelyne Berille +12 more
TL;DR: Treatment with docetaxel is associated with significant prolongation of survival, and at a dose of 75 mg/m(2), the benefits of docetAXel therapy outweigh the risks.
Prospective R andomized T rial o f D ocetaxel V ersus B est Supportive C are i n P atients W ith N on-Small-Cell L ung Cancer P reviously T reated W ith P latinum-Based Chemotherapy
F A Shepherd,J. Dancey,Rodryg Ramlau,Karin Mattson,Richard J. Gralla,Nathan Levitan,Laurent Gressot,Mark Vincent,Ronald L. Burkes,Susan Coughlin,Yong Kim,Jocelyne Berille +11 more
TL;DR: Treatment with docetaxel is associated with significant prolongation of survival, and at a dose of 75 mg/m 2 , the benefits of docetAXel therapy outweigh the risks.